Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Manganese-primed anti-PD-1 and chemotherapy in advanced biliary tract cancer
NCT04004234Phase 2Unknown
- Sponsor
- Chinese PLA General Hospital
- Start
- Mar 2019
- Primary completion
- Aug 2020
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
A Phase 2 trial of manganese chloride in biliary tract cancer (BTC), sponsored by Chinese PLA General Hospital. Status: unknown.
02
Drugs
manganese chloride
03
Conditions
biliary tract cancer (BTC)
Beyond the preview
Go deeper on NCT04004234.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04004234.